期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

免疫抑制治疗在肾移植中的应用进展及对肾科医师的启示 被引量：2

原文传递
导出
摘要 免疫抑制治疗在肾移植界占据着极为重要的地位。随着近年来新型免疫抑制剂的不断问世，免疫抑制方案的推陈出新，都直接或间接影响了非移植性肾脏疾病的治疗思路，给肾科医师带来丰富的启示。本文就新型免疫抑制剂、免疫抑制方案在肾移植中的应用进展及其对肾科医师的启示作一概述。
作者 陆福明
机构地区 复旦大学附属华山医院肾脏科
出处 《中华肾脏病杂志》 CAS CSCD 北大核心 2006年第10期643-647,共5页 Chinese Journal of Nephrology
关键词 免疫抑制治疗 肾移植 医师 肾科 新型免疫抑制剂 免疫抑制方案 肾脏疾病 间接影响
分类号 R699 [医药卫生—泌尿科学]
  • 相关文献

参考文献36

  • 1Abraham RT. Mammalian target of rapamycin: immunosuppressive drugs uncover a novel pathway of cytokine receptor signaling. Cur Opin lmmunol, 1998, 10:330-336.
  • 2MacDonald AS, RAPAMUNE Global Study Group. A worldwide phase III, randomized, controlled, safety and efficacy study of a slrolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts.Transplantation, 2001, 71:271-280.
  • 3Stallone G, Di Paolo S, Schena A, et al. Early withdrawal of cyclosporine A improves 1-year kidney graft structure and function in sirolimus-treated patients. Transplantation, 2003,75 : 998-1003.
  • 4Xu X, Shen J, Mall JW, et al. In vitro and in vivo antitumor activity of a novel immunomodulatory drug, leflunomide:mechanisms of action. Biochem Pharmacol, 1999, 58 : 1405-1413.
  • 5Hardinger KL, Wang CD, Schnitzler MA, et al. Prospective,pilot, open-label, short-term study of conversion to leflunomide reverses chronic renal allograft dysfunction. Am J Transplant,2002, 2 : 867-871.
  • 6Pan F, Ebbs A, Wynn C, et al. FK778, a powerful new immunosuppressant, effectively reduces functional and histologic changes of chronic rejection in rat renal allografts.Transplantation, 2003, 75: 1110-1114.
  • 7Vanrenterghem Y, van Hooff JP, Klinger M, et al. The effects of FK778 in combination with tacrolimus and steroids:a phase II multicenter study in renal transplant patients.Transplantation, 2004, 78: 9-14.
  • 8Knechtle SJ, Fernandez LA, Pirsch JD, et al. Campath-1H in renal transplantation : The University of Wisconsin experience. Surgery, 2004, 136:754-760.
  • 9Calne R, Moffatt SD, Friend PJ, et al. Prope tolerance with induction using Campath 1H and low-dose cyclosporin monotherapy in 31 cadaveric renal allograft recipients. Nippon C, eka Gakkai Zasshi, 2000, 101: 301-306.
  • 10Malek SK, Obmann MA, Gotoff RA, et al. Campath-1H induction and the incidence of infectious complications in adult renal transplantation. Transplantation, 2006, 81 : 17-20.

二级参考文献35

  • 1黄茂芹 周森 陈裕盛.霉酚酸酯治疗肾病综合征8例观察.中华肾脏病杂志,2000,16(6):386-386.
  • 2Briggs WA, Choi M J, Paul J, et al. Successful mycophenolate mofitel treatment of glomerular disease. J Am Kidney Dis, 1998,31: 213-217.
  • 3Dooley MA, Cosio FG, Nachman PH, et al. Mycophenolate mofetil therapy in lupus nephritis: clinical observations. J Am Soc Nephrol, 1999, 10: 833-839.
  • 4Schwarz A. New aspects of the treatment of nephrotic syndrome. J Am Soc Nephrol, 2001, 12: s44-s47.
  • 5Eugui EM, Almquist SJ, Muller CD, et al. Lymphocyte-selective cytostatic and immunosuppressive effects of mycophenolic acid in vivo: role of deoxyguanosine nucleotide depletion. Scand J Immunol, 1991,33: 161-173.
  • 6Choi MJ, Eustace JA, Gimenez LF, et al. Mycophenolate mofetil treatment for primary glomerulopathies. J Am Soc Nephrol, 2000,10: A0449.
  • 7Flanc RS, Roberts MA, Strippoli GF, et al.Treatment of diffuse proliferative lupus nephritis: a meta-analysis of randomized controlled trials.Am J Kidney Dis,2004,43:197-208.
  • 8Breedveld FC, Dayer JM.Leflunomide: mode of action in the treatment of rheumatoid arthritis.Ann Rheum Dis, 2000,59:841-849.
  • 9Li EK, Tam LS, Tomlinson B.Leflunomide in the treatment of rheumatoid arthritis.Clin Ther,2004,26: 447-459.
  • 10Remer CF, Weisman MH, Wallace DJ.Benefits of leflunomide in systemic lupus erythematosus: a pilot observational study.Lupus,2001,10:480-483.

共引文献154

同被引文献32

引证文献2

二级引证文献3

中华肾脏病杂志
2006年 第10期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部